Onkoloji Hastalarına Kardiyovasküler Cerrahi Yaklaşımı

Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-68

Azpitarte J. Cardiac surgery in the cancer patient. Rev Esp Cardiol 2008 Apr;61(4):349-51

Yeh ETH, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C et al Cardiovascular complications of cancer therapy. Circulation 2004;109: 3122–31

Carrascal Y, Gualis J, Arévalo A, Fulquet E, Flórez S, Rey J, et al. Cirugía cardiaca con circulación extracorpórea en pacientes oncológicos: influencia en la morbimortalidad quirúrgica y la supervivencia. Rev Esp Cardiol. 2008;61:369-75

Baz JA, Mauri J, Albarrán A, Pinar E. Registro Español de Hemodinámica y Cardiología Intervencionista. XVI Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2006). Rev Esp Cardiol 2007;60:1273-89

Schouten O, van Domburg RT, Bax JJ, de Jaegere PJ, Dunkelgrun M, Feringa HHH, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007;49:122-4

Schoenmakers MCJ, van Boven W-J, van den Bosch J, van Swieten HA Comparison of on pump or off-pump coronary artery revascularization with lung resection. Ann Thorac Surg. 2007;84:504-9

Lorusso R, Vizzardi E, Johnson DM ve ark. Cardiac surgery in adult patients with remitted or active malignancies: a review of preoperative screening, surgical management and short and long-term postoperative results. Eur J Cardiothorac Surg 2018;54:10–8.

Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A, et al Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol. 206;48:2258-62

Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation. 2006;114:2474-81

Chang AS, Smedira NG, Chang CL, Benavides MM, Myhre U, Feng F, et al. Cardiac surgery after mediastinal radiation: extent of exposure influences outcome. J Thorac Cardiovasc Surg. 2007;133: 404-13

Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999;15:816-23

Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE et al. ACC/ AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. Circulation 2007;116:e418–500

Salvatorelli E, Menna P, Cantalupo E, Chello M, Covino E, Wolf FI et al. The concomitant management of cancer therapy and cardiac therapy. Biochim Biophys Acta 2015;1848:2727– 37

Vieira RD, Pereira AC, Lima EG, Garzillo CL, Rezende PC, Favarato D et al. Cancer-related deaths among different treatment options in chronic coronary artery disease: results of a 6-year follow-up of the MASS II study. Coron Artery Dis 2012;23:79–84

Fecher AM, Birdas TJ, Haybron D, Papasavas PK, Evers D, Caushaj PF. Cardiac operations in patients with hematologic malignancies. Eur J Cardiothorac Surg 2004;25:537–40

Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi J. Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease. Eur Heart J 2014;35:612–23

Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 2013;11:223–33